Apoptotic and Novel Farnesyltransferase Inhibitor Preclinical Antitumor Activity of BMS-214662, a Highly

Abstract

BMS-214662 is a potent and selective inhibitor of farnesyltransferase (FTI). In rodent fibroblasts transformed by oncogenes, BMS-214662 reversed the H-Ras-transformed phenotype but not that of K-Ras or other oncogenes. In soft agar growth assays, BMS-214662 showed good potency in inhibiting H-ras-transformed rodent cells, A2780 human ovarian carcinoma tumor… (More)

Topics

15 Figures and Tables

Slides referencing similar topics